AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in AEON Biopharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q1 2026
- Shares held
- 12.8M
- +9.96M (+350.6%) vs. Q1 2026
- Total value
- $9.22M
- +$6.41M (+229.0%) vs. Q1 2026
- New holders
- 2
- 6 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 59 | $42 | 0.00% | +59 | New |
| Wells Fargo & Company | 90 | $65 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 95 | $69 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 150 | $108 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 170 | $122 | 0.01% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 232 | $167 | 0.00% | +127+121.0% | Added |
| Wolff Wiese Magana LLC | 567 | $408 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,100 | $791 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,567 | $1.85K | 0.00% | +2,097+446.2% | Added |
| BlackRock, Inc. | 2,834 | $2.04K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,062 | $3.64K | 0.00% | +880+21.0% | Added |
| Citigroup Inc | 7,315 | $5.26K | 0.00% | +6,573+885.8% | Added |
| LPL Financial LLC | 11,507 | $8.28K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 13,713 | $9.86K | 0.00% | −989−6.7% | Reduced |
| StoneX Group Inc. | 18,953 | $14.9K | 0.00% | +18,953 | New |
| Formidable Asset Management, LLC | 20,024 | $19.7K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 42,353 | $30.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 90,529 | $65.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 95,311 | $68.6K | 0.00% | +8,249+9.5% | Added |
| Dauntless Investment Group, LLC | 12,490,154 | $8.98M | 15.58% | +9,962,379+394.1% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,424−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,376−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −58−100.0% | Sold out |